# Efficacy Study of LV Assist Device to Treat Patients With Cardiogenic Shock (ISAR-SHOCK)

> **NCT00417378** · PHASE4 · COMPLETED · sponsor: **Deutsches Herzzentrum Muenchen** · enrollment: 26 (actual)

## Conditions studied

- Shock, Cardiogenic
- Myocardial Infarction

## Interventions

- **DEVICE:** Left Ventricular Assist Device Impella LP 2.5
- **DEVICE:** Intraaortic Balloon Pump

## Key facts

- **NCT ID:** NCT00417378
- **Lead sponsor:** Deutsches Herzzentrum Muenchen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2007-11-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00417378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00417378, "Efficacy Study of LV Assist Device to Treat Patients With Cardiogenic Shock (ISAR-SHOCK)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00417378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*